DarioHealth
DRIO
8 hedge funds and large institutions have $503K invested in DarioHealth in 2016 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 1 closing their positions.
0.01% more ownership
Funds ownership: 0% → 0.01% (+0.01%)
11% less funds holding
Funds holding: 9 → 8 (-1)
12% less capital invested
Capital invested by funds: $572K → $503K (-$69K)
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$1.31K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$11.8K |
| 2 |
BFM
Boston Financial Management
Boston,
Massachusetts
|
-$6.53K |
| 3 |
BA
Bard Associates
Chicago,
Illinois
|
-$3.92K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3K |
| 5 |
PVH
Psagot Value Holdings
Tel Aviv,
Israel
|
-$1.31K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BA
1
Bard Associates
Chicago,
Illinois
| $395K | -$3.92K | -3 | -1% |
|
|
2
Goldman Sachs
New York
| $45K | -$11.8K | -9 | -20% |
|
|
PVH
3
Psagot Value Holdings
Tel Aviv,
Israel
| $38K | -$1.31K | -1 | -3% |
|
4
Bank of Montreal
Toronto,
Ontario, Canada
| $16K | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $6K | +$1.31K | +1 | +25% |
|
|
AG
6
Advisor Group
Phoenix,
Arizona
| $2K | – | – | – |
|
7
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
|
BFM
8
Boston Financial Management
Boston,
Massachusetts
| – | -$6.53K | -5 | -17% |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| – | -$3K | -2 | Closed |
|
DRIO Hedge Fund Activity: Q4 2016 in Review
8 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in DarioHealth (DRIO) for Q4 2016, worth a combined $503K — down 12% from $572K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of DRIO and 0 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $1.31K. The largest seller was Goldman Sachs, cutting an estimated $11.8K.
- 8 institutional investors held DarioHealth (DRIO) as of Q4 2016, down from 9 in Q3 2016.
- Funds reported $503K of DarioHealth stock for Q4 2016, down 12% quarter-over-quarter.
- 0 funds opened new DarioHealth positions in Q4 2016 and 1 closed out, a net change of -1 holder.
- The largest DarioHealth buyer in Q4 2016 was UBS Group, an estimated $1.31K added.
- The largest DarioHealth seller in Q4 2016 was Goldman Sachs, an estimated $11.8K sold.
Based on aggregated 13F filings for Q4 2016.